Clinical Trials on Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) in New Zealand

Total 3 results

Ultragenyx Pharmaceutical Inc

Completed

Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Treated Under Expanded Access Program

Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)

United States
Ultragenyx Pharmaceutical Inc

Recruiting

Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program

Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)

United States, Canada
Arbor Research Collaborative for Health
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...

Recruiting

Longitudinal Study of Mitochondrial Hepatopathies (MITOHEP)

End Stage Liver Disease | Mitochondrial Diseases | Acute Liver Failure | Respiratory Chain Deficiencies, Mitochondrial | Disorder of Fatty Acid Oxidation

United States, Canada

3

Subscribe